HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prasanthi Ganesa Selected Research

IDM 2101

9/2008Induction of immune responses and clinical efficacy in a phase II trial of IDM-2101, a 10-epitope cytotoxic T-lymphocyte vaccine, in metastatic non-small-cell lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Prasanthi Ganesa Research Topics

Disease

1Neoplasms (Cancer)
09/2008
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
09/2008
1Carcinoid Tumor (Carcinoid)
04/2008
1Cushing Syndrome
04/2008

Drug/Important Bio-Agent (IBA)

1VaccinesIBA
09/2008
1IDM 2101IBA
09/2008
1EpitopesIBA
09/2008
1AntigensIBA
09/2008
1Adrenocorticotropic Hormone (ACTH)FDA Link
04/2008

Therapy/Procedure

1Immunotherapy
09/2008